Capital International’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Capital International's RPRX Position: Q3 2026 in Review
Capital International increased its Royalty Pharma (RPRX) stake by 2.1% in Q3 2026, buying an estimated $707K and bringing the position to 591,781 shares worth $34.5M. The position accounts for 1.11% of the portfolio, ranked #23.
Capital International first reported a position in RPRX in Q2 2025 and has held it in 6 quarters since. 593 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Capital International held 591,781 shares of Royalty Pharma worth $34.5M as of Q3 2026.
- Capital International bought 11,980 Royalty Pharma shares in Q3 2026, an estimated $707K.
- Royalty Pharma made up 1.11% of Capital International's portfolio in Q3 2026, its #23 holding.
- Capital International first reported a position in Royalty Pharma in Q2 2025 and has held it in 6 quarters since.
- 593 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Capital International's 13F filing for Q3 2026, filed 12 Nov 2026.